Search Results 31-40 of 15077 for Proto-oncogene
The team is exposing, at the molecular level, the routes that aggressive tumor cells take to adapt and survive high levels of chromosomal instability (CIN). Her ...
... oncogenic,” Dr. Anastasiadis says. “We believe that loss of the apical PLEKHA7-microprocessor complex is an early and somewhat universal event in cancer ...
(ALK), B-Raf proto-oncogene (BRAF) or ROS proto-oncogene 1 (ROS1) mutations who have not received appropriate therapies targeting these mutations and ...
Overview · Describing a paradigm shift for the tumor suppressor FoxO3a, whereby our research team identified a new oncogenic role promoting tumor growth ...
About this study. The purpose of this study is to use genomic and proteomic analyses to identify possible diagnostic markers and potential drugs for ...
Mayo Clinic investigators believe a novel proton therapy delivery technique may bring fundamental change to radiation oncology treatment paradigms, ...
Cancer Biology. Sections. Overview · Faculty; Research Research. Focus Areas · Cancer Disparities · Cancer Stem Cells · Cancer Systems Biology · Oncogenic Gene ...
The lab team has confirmed activation of this signaling pathway by oncogenic KRas as a key event driving the development of pancreatic cancer. The lab's ...
Chromosomal errors are a hallmark of cancer cells. Defects in the genome derived from the incorrect separation of chromosomes (and the DNA packed within) in ...
Mayo Clinic Research Core Facilities: Molecular development cores produce monoclonal and polyclonal antibodies and transgenic and knockout mice.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.